Works matching DE "THERAPEUTIC use of monoclonal antibodies"

Results: 5000
    1

    Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials.

    Published in:
    Drugs & Aging, 2025, v. 42, n. 6, p. 583, doi. 10.1007/s40266-025-01212-6
    By:
    • Vaz Ferreira, Ana;
    • Delaye, Matthieu;
    • Pages, Arnaud;
    • Hollebecque, Antoine;
    • Gazzah, Anas;
    • Bahleda, Rastio;
    • Michot, Jean-Marie;
    • Danlos, Francois-Xavier;
    • Seknazi, Lauren;
    • Goldschmidt, Vincent;
    • Hénon, Clémence;
    • Sakkal, Madonna;
    • Smolenschi, Cristina;
    • Champiat, Stéphane;
    • Marabelle, Aurelien;
    • Loriot, Yohann;
    • Nagera Lazarovici, Céline;
    • Ap-Thomas, Zoé;
    • Beraud Chaullet, Geoffroy;
    • Ponce Aix, Santiago
    Publication type:
    Article
    2
    3

    Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 6, p. 542, doi. 10.5858/arpa.2024-0014-OA
    By:
    • Zhenhao Qi;
    • Ha, Thomas;
    • Wenqin Feng;
    • Karnoub, Maha;
    • Pereira, Kaline;
    • Ryota Shiga;
    • Smit, Egbert F.;
    • Yasushi Goto;
    • De Langen, Adrianus Johannes;
    • Koichi Goto;
    • Velasco Roth, Anne Marie;
    • Khambata-Ford, Shirin
    Publication type:
    Article
    4
    5
    6
    7

    Fatal Borealpox in an Immunosuppressed Patient Treated With Antivirals and Vaccinia Immunoglobulin—Alaska, 2023.

    Published in:
    Clinical Infectious Diseases, 2025, v. 80, n. 5, p. 1053, doi. 10.1093/cid/ciae536
    By:
    • Rogers, Julia H;
    • Westley, Benjamin;
    • Mego, Thomas;
    • Newell, Katherine G;
    • Laurance, John;
    • Smith, Lisa;
    • Parker, Jayme;
    • Park, Sarah Y;
    • Venkatasubrahmanyam, Shivkumar;
    • Noll, Nicholas;
    • Bercovici, Sivan;
    • Rao, Agam K;
    • McCollum, Andrea M;
    • Davidson, Whitni;
    • Carson, William C;
    • Townsend, Michael B;
    • Doty, Jeffrey B;
    • Hutson, Christina;
    • Li, Yu;
    • Wilkins, Kimberly
    Publication type:
    Article
    8
    9

    Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study.

    Published in:
    Arthritis & Rheumatology, 2025, v. 77, n. 5, p. 560, doi. 10.1002/art.43059
    By:
    • Dörner, Thomas;
    • Bowman, Simon J.;
    • Fox, Robert;
    • Mariette, Xavier;
    • Papas, Athena;
    • Grader‐Beck, Thomas;
    • Fisher, Benjamin A.;
    • Barcelos, Filipe;
    • De Vita, Salvatore;
    • Schulze‐Koops, Hendrik;
    • Moots, Robert J.;
    • Junge, Guido;
    • Woznicki, Janice;
    • Sopala, Monika;
    • Avrameas, Alexandre;
    • Luo, Wen‐Lin;
    • Hueber, Wolfgang
    Publication type:
    Article
    10

    Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf088
    By:
    • Valsecchi, Anna Amela;
    • Pisegna, Simona;
    • Antonuzzo, Andrea;
    • Arpino, Grazia;
    • Bianchini, Giampaolo;
    • Biganzoli, Laura;
    • Colloca, Giuseppe Ferdinando;
    • Criscitiello, Carmen;
    • Danesi, Romano;
    • Fabi, Alessandra;
    • Giusti, Raffaele;
    • Pau, Loredana;
    • Maio, Massimo Di;
    • Santini, Daniele
    Publication type:
    Article
    11
    12
    13
    14

    Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7
    By:
    • Encinas, Cristina;
    • Lozano, Virginia;
    • Hlavacek, Patrick;
    • Llinares, Julia;
    • Toribio-Castelló, Sofía;
    • Carcedo, David;
    • Asís-Montalt, Jordi;
    • Martínez-López, Joaquín
    Publication type:
    Article
    15
    16
    17
    18

    PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.

    Published in:
    Osteoporosis International, 2025, v. 36, n. 6, p. 951, doi. 10.1007/s00198-025-07440-1
    By:
    • Beaudart, Charlotte;
    • Veronese, Nicola;
    • Douxfils, Jonathan;
    • Thiyagarajan, Jotheeswaran Amuthavalli;
    • Bolzetta, Francesco;
    • Albanese, Paolo;
    • Voltan, Gianpaolo;
    • Alokail, Majed;
    • Harvey, Nicholas C.;
    • Fuggle, Nicholas R.;
    • Bruyère, Olivier;
    • Rizzoli, René;
    • Reginster, Jean-Yves
    Publication type:
    Article
    19
    20
    21

    Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial.

    Published in:
    Cancers, 2025, v. 17, n. 10, p. 1727, doi. 10.3390/cancers17101727
    By:
    • Lim, Annette M.;
    • Baker, Benjamin;
    • Lion, Peter;
    • Angel, Christopher M.;
    • Simmons, Jennifer;
    • Jackson, Bryce;
    • Magarey, Matthew;
    • Webb, Angela;
    • Nguyen, Kevin;
    • Hudson, Jo;
    • Chin, Kwang Yang;
    • Cardin, Anthony;
    • Ravi, Rajeev;
    • Morrison, Edwin;
    • Quinn, Tam;
    • Hunt, Ian;
    • Rischin, Danny
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50